GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » Long-Term Debt

Zeria Pharmaceutical Co (TSE:4559) Long-Term Debt : 円11,372 Mil (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co Long-Term Debt?

Zeria Pharmaceutical Co's Long-Term Debt for the quarter that ended in Dec. 2023 was 円11,372 Mil.

Zeria Pharmaceutical Co's quarterly Long-Term Debt declined from Jun. 2023 (円12,059 Mil) to Sep. 2023 (円12,018 Mil) and declined from Sep. 2023 (円12,018 Mil) to Dec. 2023 (円11,372 Mil).

Zeria Pharmaceutical Co's annual Long-Term Debt declined from Mar. 2022 (円18,386 Mil) to Mar. 2023 (円14,541 Mil) and declined from Mar. 2023 (円14,541 Mil) to Mar. 2024 (円7,944 Mil).


Zeria Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Zeria Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co Long-Term Debt Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,470.71 5,819.60 18,385.86 14,541.48 7,943.80

Zeria Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,541.48 12,058.67 12,018.05 11,372.10 7,943.80

Zeria Pharmaceutical Co  (TSE:4559) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Zeria Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Zeria Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Zeria Pharmaceutical Co (TSE:4559) Business Description

Traded in Other Exchanges
N/A
Address
10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines